The table below shows BioRestorative Therapies, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$23.84K
$28.07K
-
-
-
-
Gross profit
$335.86K
$372.93K
$145.80K
-
-
-
R&D
$10.09M
$6.71M
$4.03M
$3.51M
$729.06K
$876.83K
SG&A
$5.89M
BRTX annual revenue (10-K history)
BioRestorative Therapies, Inc. reported annual revenue of $359.70K for fiscal year 2025. That is down 10.3% from $401.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $36.35K (FY 2016) to $359.70K. Figures come from the company's audited annual reports as filed with the SEC.